Sökning: onr:"swepub:oai:lup.lub.lu.se:50be076f-13c6-46b2-bef1-aebd30836411" >
PKA-induced phospho...
-
Kok, MarleenNetherlands Cancer Institute
(författare)
PKA-induced phosphorylation of ER alpha at serine 305 and high PAK1 levels is associated with sensitivity to tamoxifen in ER-positive breast cancer
- Artikel/kapitelEngelska2011
Förlag, utgivningsår, omfång ...
-
2010-03-09
-
Springer Science and Business Media LLC,2011
Nummerbeteckningar
-
LIBRIS-ID:oai:lup.lub.lu.se:50be076f-13c6-46b2-bef1-aebd30836411
-
https://lup.lub.lu.se/record/1774207URI
-
https://doi.org/10.1007/s10549-010-0798-yDOI
-
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-63953URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:art swepub-publicationtype
-
Ämneskategori:ref swepub-contenttype
Anmärkningar
-
Phosphorylation of estrogen receptor alpha at serine 305 (ER alpha S305-P) by protein kinase A (PKA) or p21-activated kinase 1 (PAK1) has experimentally been associated with tamoxifen sensitivity. Here, we investigated the clinical application of this knowledge to predict tamoxifen resistance in ER-positive breast cancer patients. Using immunohistochemistry, a score including PAK1 and co-expression of PKA and ER alpha S305-P (PKA/ER alpha S305-P) was developed on a training set consisting of 103 patients treated with tamoxifen for metastatic disease, and validated on 231 patients randomized between adjuvant tamoxifen or no treatment. In the training set, PAK1 levels were associated with tumor progression after tamoxifen (HR 1.57, 95% CI 0.99-2.48), as was co-expression of PKA and ER alpha S305-P (HR 2.00, 95% CI 1.14-3.52). In the validation set, a significant tamoxifen benefit was found among the 73% patients negative for PAK1 and PKA/ER alpha S305-P (HR 0.54, 95% CI 0.34-0.87), while others (27%) were likely to have no benefit from tamoxifen (HR 0.88, 95% 0.42-1.82). The test for interaction showed a significant difference in recurrence-free survival between groups defined by PAK1 and PKA/ER alpha S305-P (P = 0.037). Elevated PAK1 and PKA/ER alpha S305-P appeared to influence tamoxifen sensitivity. Both PAK1 and PKA/ER alpha S305-P levels were associated with sensitivity to tamoxifen in breast tumors and the combination of these variables should be considered in predicting tamoxifen benefit.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Zwart, WilbertNetherlands Cancer Institute
(författare)
-
Wigerup, CarolineLund University,Lunds universitet,Patologi, Malmö,Forskargrupper vid Lunds universitet,Pathology, Malmö,Lund University Research Groups(Swepub:lu)pat-cho
(författare)
-
Fles, RenskeNetherlands Cancer Institute
(författare)
-
Hauptmann, MichaelNetherlands Cancer Institute
(författare)
-
Van't Veer, Laura J.Netherlands Cancer Institute
(författare)
-
Wessels, Lodewyk F. A.Netherlands Cancer Institute
(författare)
-
Neefjes, JacquesNetherlands Cancer Institute
(författare)
-
Stål, OlleÖstergötlands Läns Landsting,Linköpings universitet,Onkologi,Hälsouniversitetet,Onkologiska kliniken US(Swepub:liu)ollst87
(författare)
-
Linn, Sabine C.Netherlands Cancer Institute
(författare)
-
Landberg, GöranLund University,Lunds universitet,Patologi, Malmö,Forskargrupper vid Lunds universitet,Pathology, Malmö,Lund University Research Groups(Swepub:lu)pat-gla
(författare)
-
Michalides, RobNetherlands Cancer Institute
(författare)
-
Holm, CarolineLund University
(författare)
-
Netherlands Cancer InstitutePatologi, Malmö
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Breast Cancer Research and Treatment: Springer Science and Business Media LLC125:1, s. 1-121573-72170167-6806
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Kok, Marleen
-
Zwart, Wilbert
-
Wigerup, Carolin ...
-
Fles, Renske
-
Hauptmann, Micha ...
-
Van't Veer, Laur ...
-
visa fler...
-
Wessels, Lodewyk ...
-
Neefjes, Jacques
-
Stål, Olle
-
Linn, Sabine C.
-
Landberg, Göran
-
Michalides, Rob
-
Holm, Caroline
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
Breast Cancer Re ...
- Av lärosätet
-
Lunds universitet
-
Linköpings universitet